Quetiapine abuse in illicit drug users or dealers: to screen or not to screen?
Quetiapine abuse: A regional study
DOI:
https://doi.org/10.17986/blm.1395Keywords:
Quetiapine, antipsychotics, psychoactive drugs, abuse, toksikolojiAbstract
Objectives: Abuse of psychoactive drugs for therapeutic purposes is becoming more common due to their addiction potential. In many studies, quetiapine has been reported to be abused with illicit drugs. We aimed to point to the abuse and addiction potential of quetiapine by the rates of quetiapine abuse in blood samples of 4293 cases who came to our Forensic Toxicology Laboratory by using LC/MS/MS method.
Methods: All cases who were caught by law enforcement officers while using or trading drugs as a requirement of the judicial process initiated were drug users or dealers and then they were brought to our forensic toxicology laboratory to obtain blood and urine samples. Quantification in blood samples was performed in routine laboratory analysis. The cases were asked whether they used any prescription drugs. The therapeutic drug users were excluded in this study.
Results: Quetiapine was positive in 50 of 4293 cases (1.16 %). 93.8 % (n=4028) the all of the cases and all of the positive quetiapine were male. While quetiapine was used alone in 11 of 50 cases with quetiapine positivity, quetiapine was used simultaneously with one or more group of illicit drugs in the remaining 39 cases.
Conclusions: In this study, the most common use of cannabis and quetiapine was determined in cases with drugs of abuse. The monitoring of quetiapine is essential for preventing drug abuse especially in prone population such as illicit drug abusers and addicts. Forensic Toxicology Laboratories play an important role in taking necessary preventions related drug abuse.
Downloads
References
Piróg-Balcerzak A, Habrat B, Mierzejewski P. Misuse and abuse of quetiapine. Psychiatr Pol 2015;49:81–93. https://doi.org/10.12740/PP/32923.
Klein-Schwartz W, Schwartz EK, Anderson BD. Evaluation of Quetiapine Abuse and Misuse Reported to Poison Centers. J Addict Med 2014;8:195–8. https://doi.org/10.1097/ADM.0000000000000020. DOI: https://doi.org/10.1097/ADM.0000000000000020
Klein L, Bangh S, Cole J. Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics. West J Emerg Med 2017;18:243–50. https://doi.org/10.5811/westjem.2016.10.32322. DOI: https://doi.org/10.5811/westjem.2016.10.32322
Alfaro C, Khin N. Statistical Review and Evaluation. 2011.
Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 2004;29:452–7.
PIERRE JM, SHNAYDER I, WIRSHING DA, WIRSHING WC. Intranasal Quetiapine Abuse. Am J Psychiatry 2004;161:1718–1718. https://doi.org/10.1176/appi.ajp.161.9.1718. DOI: https://doi.org/10.1176/appi.ajp.161.9.1718
Dev V, Raniwalla J. Quetiapine. Drug Saf 2000;23:295–307. https://doi.org/10.2165/00002018-200023040-00003. DOI: https://doi.org/10.2165/00002018-200023040-00003
Cha HJ, Song MJ, Lee K-W, Kim EJ, Kim Y-H, Lee Y, et al. Dependence Potential of Tramadol: Behavioral Pharmacology in Rodents. Biomol Ther (Seoul) 2014;22:558–62. https://doi.org/10.4062/biomolther.2014.064. DOI: https://doi.org/10.4062/biomolther.2014.064
Vento AE, Kotzalidis GD, Cacciotti M, Papanti GD, Orsolini L, Rapinesi C, et al. Quetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review. Subst Use Misuse 2020;55:304–13. https://doi.org/10.1080/10826084.2019.1668013. DOI: https://doi.org/10.1080/10826084.2019.1668013
Srivastava A, Patil V, Da Silva Pereira Y. A case series of quetiapine addiction/dependence. Ger J Psychiatry 2013;16:152–5.
Piróg-Balcerzak A, Habrat B, Mierzejewski P. Misuse and abuse of quetiapine. Psychiatr Pol 2015;49:81–93. https://doi.org/10.12740/PP/32923. DOI: https://doi.org/10.12740/PP/32923
Malekshahi T, Tioleco N, Ahmed N, Campbell ANC, Haller D. Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. J Subst Abuse Treat 2015;48:8–12. https://doi.org/10.1016/j.jsat.2014.07.006. DOI: https://doi.org/10.1016/j.jsat.2014.07.006
Ramachandran S, Rosenthal M, Young J, Holmes E, Bentley JP. Subtle scales: An avenue for identification of prescription drug abuse. Res Soc Adm Pharm 2019;15:936–42. https://doi.org/10.1016/j.sapharm.2019.02.010. DOI: https://doi.org/10.1016/j.sapharm.2019.02.010
Finlayson A. Non-medical and illicit use of psychoactive drugs. vol. 34. v34 ed. Current Topic in Behavioral Neurosciences (Springer); 2017. https://doi.org/10.1007/978-3-319-60016-1. DOI: https://doi.org/10.1007/978-3-319-60016-1
Paparrigopoulos T, Karaiskos D, Liappas J. Quetiapine. J Clin Psychiatry 2008;69:162–3. https://doi.org/10.4088/JCP.v69n0122a. DOI: https://doi.org/10.4088/JCP.v69n0122a
Chiappini S, Schifano F. Is There a Potential of Misuse for Quetiapine? J Clin Psychopharmacol 2018;38:72–9. https://doi.org/10.1097/JCP.0000000000000814. DOI: https://doi.org/10.1097/JCP.0000000000000814
Oyemade A. Seroquel misuse/abuse. Psychiatry (Edgmont) 2010;7:15.
Tamburello AC, Lieberman JA, Baum RM, Reeves R. Successful removal of quetiapine from a correctional formulary. J Am Acad Psychiatry Law 2012;40:502–8.
Kaya H, Dilbaz N, Okay T, Çeflmeci U. Is quetiapine addictive?–Turkish]. Klin Psikofarmakol Bul 2009;19:32–7.
Mutlu E, Aşicioğlu F. Abuse of prescribed psychoactive drugs. Anadolu Psikiyatr Derg 2020;21:195–202. https://doi.org/10.5455/apd.53469. DOI: https://doi.org/10.5455/apd.53469
WATERS BM, JOSHI KG. Intravenous Quetiapine-Cocaine Use (“Q-Ball”). Am J Psychiatry 2007;164:173–4. https://doi.org/10.1176/ajp.2007.164.1.173a. DOI: https://doi.org/10.1176/ajp.2007.164.1.173a
Reddel SE, Bruno R, Burns L, Kirwan A, Lokuge K, Dietze P. Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs. Addiction 2014;109:295–302. https://doi.org/10.1111/add.12395. DOI: https://doi.org/10.1111/add.12395
Lee J, Pilgrim J, Gerostamoulos D, Robinson J, Wong A. Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia. Drug Alcohol Depend 2018;187:95–9. https://doi.org/10.1016/j.drugalcdep.2018.03.002. DOI: https://doi.org/10.1016/j.drugalcdep.2018.03.002
Pilgrim JL, Drummer OH. The toxicology and comorbidities of fatal cases involving quetiapine. Forensic Sci Med Pathol 2013;9:170–6. https://doi.org/10.1007/s12024-012-9404-4. DOI: https://doi.org/10.1007/s12024-012-9404-4
UNODC, United Nations Office on Drugs and Crime. World drug report 2019, Booklet 1-5. 2019. https://doi.org/10.18356/bdc264f4-en. DOI: https://doi.org/10.18356/bdc264f4-en
Ögel K. Madde Kullanım Bozuklukları Epidemiyolojisi. Türkiye Klin Dahili Tıp Bilim Derg Psikiyatr 2005;1:61–4.
Hernandez SH, Nelson LS. Prescription Drug Abuse: Insight Into the Epidemic. Clin Pharmacol Ther 2010;88:307–17. https://doi.org/10.1038/clpt.2010.154. DOI: https://doi.org/10.1038/clpt.2010.154
Downloads
Published
Issue
Section
License
Copyright (c) 2021 The Bulletin of Legal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
